Brief: Orchid Pharma Signs Licensing Agreement With Pharmasyntez To Commercialize Exblifep In Russia
07/07/2026 15:28
BRIEF-Orchid Pharma Signs Licensing Agreement With Pharmasyntez To Commercialize Exblifep In Russia July 7 (Reuters) - Orchid Pharma Ltd ORCD.NS:
ORCHID PHARMA - SIGNS LICENSING AGREEMENT WITH PHARMASYNTEZ TO COMMERCIALIZE EXBLIFEP IN RUSSIA
ORCHID PHARMA - PARTNERSHIP REPRESENTS POTENTIAL OPPORTUNITY OF ABOUT $178 MILLION OVER FIRST 10 YEARS
Source text: ID:nBSE7nJhNs
Further company coverage: ORCD.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices